tenofovir disoproxil fumarate / Generic mfg. |
NCT01671787: A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B |
|
|
| Completed | 1b | 51 | Canada, US, Europe, RoW | GS-7340, Tenofovir disoproxil fumarate, Viread | Gilead Sciences | Chronic Hepatitis B | 04/13 | 04/13 | | |
NCT00024986: Tenofovir Disoproxil Fumarate to Treat Pediatric HIV |
|
|
| Completed | 1 | 30 | US | Tenofovir DF | National Cancer Institute (NCI) | HIV Infection | | 09/05 | | |
NCT00828789: VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy Volunteer |
|
|
| Completed | 1 | 20 | RoW | Efavirenz; Tenofovir disoproxil fumarate; Telaprevir | Tibotec BVBA | Hepatitis C, HCV, HIV, AIDS | 04/09 | 04/09 | | |
NCT01205139: TMC435-TiDP16-C114 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents TMC278 and Tenofovir |
|
|
| Completed | 1 | 48 | Europe | TMC435, TDF, TMC435 + TDF, TMC435 + TMC278, TMC278 | Tibotec Pharmaceuticals, Ireland | Hepatitis C Virus | 03/11 | 03/11 | | |
NCT01480622: Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese Subjects |
|
|
| Completed | 1 | 14 | RoW | TDF tablets | GlaxoSmithKline | Hepatitis B, Chronic | 12/11 | 12/11 | | |